Skip to main content

Advertisement

Log in

Gemcitabine-induced radiation recall myositis

  • Case Report
  • Published:
Skeletal Radiology Aims and scope Submit manuscript

Abstract

Radiation recall is an uncommon phenomenon in which administration of a chemotherapeutic agent induces an acute inflammatory reaction in previously irradiated tissues, often weeks to years after completion of radiotherapy. This entity is well known to medical and radiation oncologists, however only three cases have been reported in radiology journals. We present a case of gemcitabine-induced radiation recall that manifested as myositis with associated dermatitis in the posterior thigh of a patient with remote history of localized radiotherapy for biopsy-proven breast cancer metastasis. We also present a brief literature review to update the topic of radiation recall in imaging, and emphasize the importance of knowledge of this phenomenon when considering the differential diagnosis of myositis/dermatitis in a patient who has received cancer treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. D’Angio GJ, Farber S, Maddock CL. Potentiation of X-ray effects by actinomycin D. Radiology. 1959;73:175–7.

    Article  PubMed  Google Scholar 

  2. Eckardt MA, Bean A, Selch MT, Federman N. A child with gemcitabine-induced severe radiation recall myositis resulting in a compartment syndrome. J Pediatr Hematol Oncol. 2013;35(2):156–61.

    Article  PubMed  Google Scholar 

  3. Azria D, Magne N, Zouhair A, Castadot P, Culine S, Ychou M, et al. Radiation recall: a well-recognized but neglected phenomenon. Cancer Treat Rev. 2005;31(7):555–70.

    Article  PubMed  Google Scholar 

  4. Burris 3rd HA, Hurtig J. Radiation recall with anticancer agents. Oncologist. 2010;15(11):1227–37.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Camidge R, Price A. Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol. 2001;59(3):237–45.

    Article  CAS  PubMed  Google Scholar 

  6. Boal DK, Newburger PE, Teele RL. Esophagitis induced by combined radiation and adriamycin. AJR Am J Roentgenol. 1979;132(4):567–70.

    Article  CAS  PubMed  Google Scholar 

  7. Ma LD, Taylor GA, Wharam MD, Wiley JM. "Recall" pneumonitis: adriamycin potentiation of radiation pneumonitis in two children. Radiology. 1993;187(2):465–7.

    Article  CAS  PubMed  Google Scholar 

  8. Garza LA, Yoo EK, Junkins-Hopkins JM, VanVoorhees AS. Photo recall effect in association with cefazolin. Cutis. 2004;73(1):79–80. 5.

    PubMed  Google Scholar 

  9. Extermann M, Vogt N, Forni M, Dayer P. Radiation recall in a patient with breast cancer treated for tuberculosis. Eur J Clin Pharmacol. 1995;48(1):77–8.

    Article  CAS  PubMed  Google Scholar 

  10. Parry BR. Radiation recall induced by tamoxifen. Lancet. 1992;340(8810):49.

    Article  CAS  PubMed  Google Scholar 

  11. Bostrom A, Sjolin-Forsberg G, Wilking N, Bergh J. Radiation recall–another call with tamoxifen. Acta Oncol. 1999;38(7):955–9.

    Article  CAS  PubMed  Google Scholar 

  12. Singer EA, Warren RD, Pennanen MF, Collins BT, Hayes DF. Tamoxifen-induced radiation recall dermatitis. Breast J. 2004;10(2):170–1.

    Article  PubMed  Google Scholar 

  13. Abadir R, Liebmann J. Radiation reaction recall following simvastatin therapy: a new observation. Clin Oncol (R Coll Radiol). 1995;7(5):325–6.

    Article  CAS  PubMed  Google Scholar 

  14. Del Guidice SM, Gerstley JK. Sunlight-induced radiation recall. Int J Dermatol. 1988;27(6):415–6.

    Article  PubMed  Google Scholar 

  15. Welsh JS, Torre TG, DeWeese TL, O’Reilly S. Radiation myositis. Ann Oncol. 1999;10(9):1105–8.

    Article  CAS  PubMed  Google Scholar 

  16. Burdon J, Bell R, Sullivan J, Henderson M. Adriamycin-induced recall phenomenon 15 years after radiotherapy. JAMA. 1978;239(10):931.

    Article  CAS  PubMed  Google Scholar 

  17. Barlesi F, Tummino C, Tasei AM, Astoul P. Unsuccessful rechallenge with pemetrexed after a previous radiation recall dermatitis. Lung Cancer. 2006;54(3):423–5.

    Article  PubMed  Google Scholar 

  18. Friedlander PA, Bansal R, Schwartz L, Wagman R, Posner J, Kemeny N. Gemcitabine-related radiation recall preferentially involves internal tissue and organs. Cancer. 2004;100(9):1793–9.

    Article  PubMed  Google Scholar 

  19. Pentsova E, Liu A, Rosenblum M, O’Reilly E, Chen X, Hormigo A. Gemcitabine-induced myositis in patients with pancreatic cancer: case reports and topic review. J Neurooncol. 2012;106(1):15–21.

    Article  PubMed  Google Scholar 

  20. Saif MW, Sellers S, Russo S. Gemcitabine-related radiation recall in a patient with pancreatic cancer. Anticancer Drugs. 2006;17(1):107–11.

    Article  CAS  PubMed  Google Scholar 

  21. Jeter MD, Janne PA, Brooks S, Burstein HJ, Wen P, Fuchs CS, et al. Gemcitabine-induced radiation recall. Int J Radiat Oncol Biol Phys. 2002;53(2):394–400.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare they have no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joshua Adam Delavan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Delavan, J.A., Chino, J.P. & Vinson, E.N. Gemcitabine-induced radiation recall myositis. Skeletal Radiol 44, 451–455 (2015). https://doi.org/10.1007/s00256-014-1996-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00256-014-1996-1

Keywords

Navigation